Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (ATEMPT): an open-label randomised controlled pilot trial

Efficacy of decentralised home-based antihypertensive treatment in older adults with multimorbidity and polypharmacy (ATEMPT): an open-label randomised controlled pilot trial

<p><strong>Background</strong> Older patients with multimorbidity and polypharmacy have been under-represented in clinical trials. We aimed to assess the effect of different intensities of antihypertensive treatment on changes in blood pressure, major safety outcomes, and patient-r...

Full description

Bibliographic Details
Main Authors:	Majert, J, Nazarzadeh, M, Ramakrishnan, R, Bidel, Z, Hedgecott, D, Perez-Crespillo, A, Turpie, W, Akhtar, N, Allison, M, Rao, S, Gudgin, B, McAuley, M, A'Court, C, Billot, L, Kotecha, D, Potter, J, Rahimi, K
Format:	Journal article
Language:	English
Published:	Elsevier 2024

Similar Items

Antihypertensive treatment evaluation in a multimorbidity and polypharmacy trial (atempt): a randomised controlled trial
by: Rahimi, K, et al.
Published: (2023)

Polypharmacy Management in Elderly Patients with Multimorbidity
by: Wanyu PAN, Chunhui ZHANG, Zhenxiang ZHANG, Jing CHEN, Yongxia MEI, Beilei LIN, Shaoyang WANG, Qinghua ZHAI
Published: (2022-05-01)

Multimorbidity or Polypharmacy: Two Sides of the Same Coin?
by: Carol Sinnott, et al.
Published: (2015-01-01)

MULTIMORBID AND POLYPHARMACY IN CLINICAL CARDIOLOGY IN TERMS OF THE CLINICAL CASE
by: A. O. Radchenko, et al.
Published: (2017-06-01)

Multimorbidity associated with polypharmacy and negative self-perception of health
by: Gustavo Cavalcanti, et al.
Published: (2017-10-01)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
by: Fiona von Buedingen, et al.
Published: (2018-07-01)

Polypharmacy in multimorbid older adults: protocol for a systematic review
by: Caroline Sirois, et al.
Published: (2017-05-01)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
by: Ross McQueenie, et al.
Published: (2020-01-01)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
by: Noemí Villén, et al.
Published: (2022-12-01)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
by: Yong Zhao, et al.
Published: (2023-07-01)

Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
by: Lorena Martínez-Montesinos, et al.
Published: (2023-02-01)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015.
by: Marjan van den Akker, et al.
Published: (2019-01-01)

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
by: Reeve, J, et al.
Published: (2022)

Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
by: Tal Sella, et al.
Published: (2022-11-01)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
by: Ross McQueenie, et al.
Published: (2021-01-01)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
by: Caroline McCarthy, et al.
Published: (2020-09-01)

Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
by: Kathryn Nicholson, PhD, et al.
Published: (2024-04-01)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
by: Agnieszka Kotalczyk, et al.
Published: (2022-03-01)

Evaluation of The Association of Medication Adherence With Polypharmacy and Multimorbidity in Patients With Coronary Artery Disease
by: Sercan Bulut, et al.
Published: (2020-12-01)

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
by: Joanne Reeve, et al.
Published: (2022-07-01)

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial
by: Mayne, KM, et al.
Published: (2024)

Antihypertensive treatment and risk of cancer: individual participant data meta-analysis of randomized clinical trials
by: Narzarzedah, M, et al.
Published: (2021)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
by: Juan Wang, et al.
Published: (2022-01-01)

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
by: Laberge M, et al.
Published: (2021-05-01)

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
by: Nazarzadeh Larzjan, M, et al.
Published: (2021)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
by: Monika Kozieł, et al.
Published: (2021-01-01)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study.
by: Katharina Tabea Jungo, et al.
Published: (2022-01-01)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
by: Stefan Zechmann, et al.
Published: (2019-05-01)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
by: Juan Wang, et al.
Published: (2022-05-01)

A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy
by: González-González, AI, et al.
Published: (2020)

The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study
by: Elnaz Faramarzi, et al.
Published: (2023-06-01)

Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice
by: Müller, BS, et al.
Published: (2020)

GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice
by: Kuberska, K, et al.
Published: (2021)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01)

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
by: Caroline Sirois, et al.
Published: (2019-08-01)

Interplay of multimorbidity and polypharmacy on a community dwelling frail elderly cohort in the peri-urban slums of Delhi, India
by: Meely Panda, et al.
Published: (2020-01-01)

Fifteen-year trajectories of multimorbidity and polypharmacy in Dutch primary care-A longitudinal analysis of age and sex patterns.
by: Rein Vos, et al.
Published: (2022-01-01)

Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada.
by: Colleen J Maxwell, et al.
Published: (2021-01-01)

Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study
by: Maria Beatrice Zazzara, et al.
Published: (2023-02-01)

Predictors of falls and hospital admissions in people with cognitive impairment in day-care: role of multimorbidity, polypharmacy, and potentially inappropriate medication
by: Jennifer Scheel, et al.
Published: (2022-08-01)